NCT00995306View on ClinicalTrials.gov

Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s)

PHASE3CompletedINTERVENTIONAL
Enrollment

695

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

June 30, 2004

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Civamide (Zucapsaicin)

"Civamide Cream 0.075%, TID for 12 weeks~Civamide Cream 0.01%, TID for 12 weeks"

All Listed Sponsors
lead

Winston Laboratories

INDUSTRY

NCT00995306 - Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s) | Biotech Hunter | Biotech Hunter